Chao Wang

Chao (Jack) Wang is an experienced research scientist with a strong background in molecular biology and pharmacology. Currently serving as an Associate Research Scientist I at Caris Life Sciences since January 2022, Chao previously held roles at Indiana University School of Medicine as a Research Analyst I, focusing on combination therapies for metastatic triple-negative breast cancer. Earlier experiences include a position as a Molecular Biologist at Eli Lilly and work as a Graduate Research Assistant at Indiana University School of Medicine, where projects involved drug repositioning for cancer treatment and the screening of targeted cancer therapeutics. Chao's educational background includes a Ph.D. in Molecular and Cellular Biology from Arizona State University and a Ph.D. in Medical and Molecular Genetics from Indiana University School of Medicine, alongside a Master's in Pharmacology and a Bachelor's in Pharmaceutics from Shenyang Pharmaceutical University.